Foresite Capital Management VI »

Ataibeckley shares owned by Foresite Capital Management VI

Quarter-by-quarter ownership of Ataibeckley (ATAI) shares owned by Foresite Capital Management VI from 13F filings

Historical chart of Foresite Capital Management VI investment in Ataibeckley

Tip: Access up to 7 years of quarterly data

All positions including Ataibeckley held by Foresite Capital Management VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ataibeckley by Foresite Capital Management VI

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.7M 2.8M 3.54

More positions owned by Foresite Capital Management VI

Cg Oncology (CGON)
Alumis (ALMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Corvus Pharmaceuticals (CRVS)
Denali Therapeutics (DNLI)
Agios Pharmaceuticals (AGIO)
Verastem (VSTM)
Kymera Therapeutics (KYMR)
Minerva Neurosciences (NERV)
Celldex Therapeutics (CLDX)
Ataibeckley (ATAI)
Hinge Health Cl A (HNGE)
Crinetics Pharmaceuticals In (CRNX)
OnKure Therapeutics Com Cl A (OKUR)
Jade Biosciences (JBIO)

View all positions for Foresite Capital Management VI

Top funds holding Ataibeckley

Deep Track Capital
Vanguard Capital Management
UBS Group
BlackRock
Millennium Management
Morgan Stanley
Candriam Luxembourg S.C.A.
Foresite Capital Management VI
Marshall Wace
Geode Capital Management
Two Sigma Investments
Newtyn Management
Eagle Health Investments
Vanguard Fiduciary Trust
Moore Capital Management

View all funds holding Ataibeckley